Search results
Added:
1 month ago
Filmed onsite at EASD 2025, this on-demand series features key insights from Prof Dirk Müller-Wieland and Dr Rahul Aggarwal to interpret the latest data on eicosapentaenoic acid(EPA), including the latest sub-analysis of the REDUCE-IT trial, whichanalysed the effectiveness of icosapent ethyl (IPE) on CV risk by triglyceride-glucose (TyG) index - an indicator of insulin resistance and risk of type…
View more
Added:
2 months ago
Added:
1 year ago
Added:
2 years ago
EASD 2023 – Dr Carl G Streed (Boston University School of Medicine, US) joins us to summarise healthcare disparities among the LGBTQ+ population.In this interview, Dr Streed discusses the available evidence and explains the minority stress model. This model suggests that experiences of discrimination and stress contribute to worse health outcomes in the LGBTQ community. This can lead to mental…
View more
Added:
3 weeks ago
Source:
Arrhythmia Academy
Atrial fibrillation (AF) has a complex genetic architecture, and a new study suggests that integrating information on common, rare, and somatic genetic variants can significantly improve risk prediction. Researchers developed an integrated genomic model (IGM-AF) that, when combined with clinical factors, enhanced the stratification of individuals at risk for incident AF.¹This cohort study…
View more
Added:
1 month ago
Source:
Radcliffe Cardiology
AUTHOR: Jordan RanceRisk stratification for primary prevention implantable cardioverter-defibrillator (ICD) placement in patients with cardiac sarcoidosis remains a clinical challenge, partly due to inconsistencies in diagnostic criteria and the variable course of the disease. A new study published in the European Heart Journal suggests that cardiovascular magnetic resonance (CMR) phenotyping has…
View more
Added:
2 months ago
Added:
1 month ago
Source:
Arrhythmia Academy
A strategy of actively increasing plasma potassium to high-normal levels significantly lowered the risk of arrhythmia events in high-risk patients with an implantable cardioverter–defibrillator (ICD), according to results from the POTCAST trial.¹˒² The findings were presented at the European Society of Cardiology (ESC) Congress 2025 and simultaneously published in the New England Journal of…
View more
Added:
2 months ago
Source:
Arrhythmia Academy
Complete heart block (CHB) is a life-threatening arrhythmia, yet current electrocardiography (ECG)-based methods for risk stratification have limited predictive power. A new study has detailed the development and validation of a novel artificial intelligence-enhanced ECG (AI-ECG) model that can accurately predict the risk of incident CHB, significantly outperforming traditional risk markers.¹The…
View more
Added:
1 year ago